Is COAG or HCSG more profitable?

HCSG runs the higher net margin — COAG at 0.00% versus HCSG at 6.59%.

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) vs Healthcare Services Group, Inc. (HCSG)

A side-by-side comparison of Hemab Therapeutics Holdings, Inc. Common Stock and Healthcare Services Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

COAG

Hemab Therapeutics Holdings, Inc. Common Stock

$1.33B

$28.43HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT

HCSG

Healthcare Services Group, Inc.

$1.44B

$21.00HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT

Total return — COAG vs HCSG

growth of $100 · dividends reinvested · last 1y

COAG -10.0% (-10.0%/yr)HCSG -1.7% (-1.7%/yr)HCSG compounded faster over this window

COAG HCSG

COAG vs HCSG: by the numbers

•HCSG is the larger company ($1.44B vs $1.33B market cap).
•HCSG is profitable (6.59% net margin) while COAG runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	COAG	HCSG
P/E ratio	N/A	12.28
Forward P/E	N/A	17.51
P/S ratio	N/A	0.77
P/B ratio	2.92	2.78
EV / EBITDA	N/A	8.88
FCF yield	N/A	10.51%

Profitability

Metric	COAG	HCSG
Gross margin	0.00%	17.33%
Operating margin	0.00%	7.03%
Net margin	0.00%	6.59%
ROE	N/A	23.70%
ROIC	-38.09%	16.83%

Growth (annualized)

Metric	COAG	HCSG
Revenue CAGR (5Y)	N/A	2.29%
EPS CAGR (5Y)	N/A	-9.08%
FCF CAGR (5Y)	N/A	-8.15%
Total return CAGR (5Y)	N/A	-2.00%

Frequently asked

Is COAG or HCSG more profitable?: HCSG runs the higher net margin — COAG at 0.00% versus HCSG at 6.59%.

Go deeper

Full COAG analysis Full HCSG analysis Interactive comparison tool

Dig into the metrics

Healthcare Services P/E ratio Hemab Therapeutics Holdings, Inc. Common Stock ROE Healthcare Services ROE Hemab Therapeutics Holdings, Inc. Common Stock operating margin Healthcare Services operating margin Hemab Therapeutics Holdings, Inc. Common Stock revenue growth Healthcare Services revenue growth Hemab Therapeutics Holdings, Inc. Common Stock free cash flow Healthcare Services free cash flow

Hemab Therapeutics Holdings, Inc. Common Stock & Healthcare Services appear in these rankings

Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.